2D·

ASML: A Brilliant Quarter — But Is Now the Right Time to Buy?

attachment

$ASML (+1.35%) has once again made headlines following the release of its Q2 2026 results, and for good reason. The Dutch semiconductor equipment giant — the world's sole manufacturer of EUV lithography machines — delivered a quarter that exceeded expectations across the board, reinforcing its status as Europe's most valuable listed company.


Record results, guidance raised for the third time

The numbers speak for themselves. ASML reported Q2 2026 revenue of €9.3 billion, comfortably ahead of the analyst consensus of approximately €8.4–9 billion, and net income came in at nearly €3 billion. Perhaps more significantly, management raised its full-year 2026 revenue guidance for the third time this year, now targeting €43–45 billion — a figure that stands well above the prior Bloomberg consensus of €39.3 billion. The company also announced plans to expand its production capacity for both EUV and DUV systems in order to address surging demand from chipmakers racing to build AI infrastructure.

The market responded positively: the stock rose approximately 7% in the sessions following the release, offering some relief after a turbulent July that had seen shares decline roughly 11% from their recent highs.


Does this make ASML a buying opportunity?

This is where the analysis becomes more nuanced — and more interesting.

Over the past twelve months, ASML's stock has risen approximately 141%, driven by the AI infrastructure boom and the company's unrivalled position in the semiconductor supply chain. The strong Q2 results largely confirm what investors already anticipated: that demand for ASML's machines is structural, not cyclical, and that the company's monopoly on EUV technology gives it extraordinary pricing power. In that sense, the results validate the euphoria that has built up around the stock — but they do not necessarily suggest that the next 12 months will mirror the last.

That said, dismissing ASML entirely would be a mistake. Several factors remain compelling. The SK Hynix order announced earlier this year — worth approximately €6.86 billion, the largest single order in ASML's history — loads the backlog further into record territory and provides multi-year revenue visibility. Memory chip demand, historically a secondary driver for ASML, has now overtaken logic foundries to represent 51% of new system sales, reflecting the scale of investment in AI-related HBM production. Furthermore, management's willingness to raise guidance three times in a single year signals genuine confidence in the demand outlook, not just short-term momentum.

The risk, however, is real. At current valuation levels, after a 141% annual gain, much of the good news is arguably already priced in. Growth-oriented stocks of this profile tend to stabilise following a period of exceptional re-rating, and any disappointment — whether from Chinese export restrictions, a slowdown in hyperscaler AI capex, or margin pressure on High-NA EUV adoption — could trigger a sharp correction. Options markets were pricing an 8.4% swing on earnings day, a level more than double ASML's historical average, suggesting that institutional investors were themselves uncertain about the near-term direction.


Bottom line

ASML remains one of the most structurally compelling stocks in Europe — arguably globally — by virtue of its monopoly position, record backlog, and the secular tailwind of AI-driven chip demand. It continues to hold the top spot in European market capitalisation at approximately $694 billion. However, for investors considering entry today, the question is not whether ASML is a great company — it clearly is — but whether the current price already reflects that greatness. There are almost certainly further gains to be made over a multi-year horizon, but the era of effortless 140% annual returns may be behind us, at least in the near term.


As always, position sizing and time horizon matter as much as stock selection.


Disclaimer: This text reflects personal analysis and does not constitute investment advice.


#asml
#results#tech

11
Join the conversation